Risk of transmission of amyloid β pathology via transfused blood products
sbulaev
24 points
6 comments
August 23, 2026
Related Discussions
Found 5 related stories in 129.4ms across 13,334 title embeddings via pgvector HNSW
- Glymphatic clearance to alleviate brain edema and Alzheimer's pathology in mice ersinesen · 44 pts · October 24, 2026 · 47% similar
- Blood cells from 80-year-old donor become stem cells with molecular age under 20 arunc · 139 pts · October 12, 2026 · 45% similar
- FDA clears blood test to aid evaluation for Alzheimer's disease dabinat · 184 pts · August 24, 2026 · 44% similar
- Clinical trial of a prion disease drug candidate begins enrolling participants luu · 29 pts · October 09, 2026 · 41% similar
- Alzheimer's trial results lend momentum to strategies targeting tau lonelyasacloud · 24 pts · July 17, 2026 · 39% similar
Discussion Highlights (1 comments)
echelon
We should be cloning monoclonal antigen free humans and harvesting blood from factories. All of medical science still imagines a world where humans are in "God's shape", denying the fact that we are machines made of systems of smaller machines. We could clone headless humans and have factories full of them. Transplants could cure all but brain cancer. Reverse aging too. Every time I meet a postdoc biologist and hear them drone on about the limits of detection, I'm furious we are overlooking the obvious answer to everything. The mechanization of the human body as a plant and lab. It's just going to take someone bold enough to do it, because people look at this as a horror. Like the first medical inquiry into cadavers being an affront to God. It would fix everything and propel the biological sciences hundreds of years into the future. We are dumb superstitious apes.